Pacira BioSciences (PCRX) Enterprise Value (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Enterprise Value of -$202.2 million for Q1 2026, up 59.04% year-over-year from -$127.1 million in Q1 2025, and up 15.2% quarter-over-quarter from -$238.4 million in Q4 2025.
Pacira BioSciences (PCRX) Enterprise Value (2010 - 2026) Analysis & Trends
Pacira BioSciences' Enterprise Value history runs 17 years deep, the most recent figure standing at -$202.2 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 59.04% year-over-year to -$202.2 million; the TTM figure through Mar 2026 stood at -$202.2 million (up 59.04% YoY), while the FY2025 annual figure was -$238.4 million, up 50.8% from the prior year.
- Enterprise Value for Q1 2026 stood at -$202.2 million, up from -$238.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$174.0 million in Q1 2023, with the low at -$493.6 million in Q1 2025.
- The 5-year median for Enterprise Value is -$316.4 million (2022), against an average of -$328.8 million.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 61.52% in 2023, then slumped 92.96% in 2024.
- Pacira BioSciences' Enterprise Value stood at -$288.7 million in 2022, then rose by 3.49% to -$278.6 million in 2023, then sank by 73.96% to -$484.6 million in 2024, then jumped by 50.8% to -$238.4 million in 2025, then grew by 15.2% to -$202.2 million in 2026.
- Business Quant data shows PCRX's Enterprise Value at -$202.2 million in Q1 2026, -$238.4 million in Q4 2025, and -$246.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -164.00 Mn |
| 10 | Pacira BioSciences | 948.67 Mn | 697.64 Mn | 148.24 Mn | -251.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -251.03 Mn |
| Mar 31, 2026 | -202.18 Mn |
| Dec 31, 2025 | -238.42 Mn |
| Sep 30, 2025 | -246.33 Mn |
| Jun 30, 2025 | -445.86 Mn |
| Mar 31, 2025 | -493.63 Mn |
| Dec 31, 2024 | -484.62 Mn |
| Sep 30, 2024 | -453.81 Mn |
| Jun 30, 2024 | -404.23 Mn |
| Mar 31, 2024 | -325.89 Mn |
| Dec 31, 2023 | -278.58 Mn |
| Sep 30, 2023 | -235.19 Mn |
| Jun 30, 2023 | -220.77 Mn |
| Mar 31, 2023 | -174.00 Mn |
| Dec 31, 2022 | -288.65 Mn |
| Sep 30, 2022 | -328.73 Mn |
| Jun 30, 2022 | -316.39 Mn |
| Mar 31, 2022 | -452.19 Mn |
| Dec 31, 2021 | -656.41 Mn |
| Sep 30, 2021 | -693.86 Mn |